Downregulated Expression of LncRNA TUBA4B Predicts Unfavorable Prognosis and Suppresses Glioma Progression by Sponging MiR-183 to Regulate SMAD4 Expression

Overview

Journal Arch Med Sci

Specialty General Medicine

Date 2024 Jul 25

PMID 39050167

Authors

Xing-Na Bao

Shang-Wei Wang

Yongfeng Li

Affiliations

Soon will be listed here.

Abstract

Introduction: Accumulating evidence has proved that long non-coding RNAs (lncRNAs) are involved in progression of glioma. Nevertheless, the role of TUBA4B in glioma remains unclear.

Material And Methods: The expression of the target gene was measured by quantitative RT-PCR. The prognostic role of TUBA4B was analyzed by Meier survival analysis. Cell proliferation, colony formation, apoptosis, cell cycle, migration and invasion were detected by MTS, soft agar colony forming assay, flow cytometry, and transwell assay. The target interaction of the target gene was validated by the luciferase reporter assay, biotin pull-down assay, and RNA immunoprecipitation.

Results: We found that the expression of TUBA4B was lower in glioma tissues and cells. Moreover, patients with a low TUBA4B expression level exhibited poorer prognosis than those with high TUBA4B expression. Meanwhile, ROC analysis revealed that TUBA4B had diagnostic value to distinguish tumor patients from the healthy population. Overexpression of TUBA4B prohibited the malignancy of glioma, such as inhibition of proliferation, decrease of colony formation, arrest of the cell cycle, decline of migration and invasion, and promotion of cell apoptosis. In addition, we found that TUBA4B directly interacted with miR-183 and negatively regulated the expression of miR-183. We also observed that SMAD4 was a downriver target of miR-183 and TUBA4B subsequently exerted its tumor-suppressive effects by coordinating the expression of SMAD4 in glioma.

Conclusions: This study revealed for the first time that TUBA4B could be a tumor suppressor gene in glioma by adjustment of the TUBA4B/miR-183/SMAD4 axis, which may provide a useful prognostic biomarker and promising therapeutic target for glioma treatment.

Citing Articles

Retracted article: Knockdown of long non-coding RNA AGAP2-AS1 suppresses the proliferation and metastasis of glioma by targeting microRNA-497-5p.

Sun Y, Shen Y, Li X Bioengineered. 2021; 15(1):1995573.

PMID: 34709983 PMC: 10802192. DOI: 10.1080/21655979.2021.1995573.

References

Wang Y, Xu G, Chen W, Pan Q, Huang K, Pan J . Detection of long-chain non-encoding RNA differential expression in non-small cell lung cancer by microarray analysis and preliminary verification. Mol Med Rep. 2014; 11(3):1925-32. DOI: 10.3892/mmr.2014.2944. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Peng Z, Liu C, Wu M . New insights into long noncoding RNAs and their roles in glioma. Mol Cancer. 2018; 17(1):61. PMC: 5817731. DOI: 10.1186/s12943-018-0812-2. View

Luo Z, Pan J, Ding Y, Zhang Y, Zeng Y . The function and clinical relevance of lncRNA UBE2CP3-001 in human gliomas. Arch Med Sci. 2018; 14(6):1308-1320. PMC: 6209712. DOI: 10.5114/aoms.2018.79004. View

Liu A, Yang F, Huang L, Zhang L, Zhang J, Zheng R . Long non-coding RNA Tubulin Alpha 4B (TUBA4B) inhibited breast cancer proliferation and invasion by directly targeting miR-19. Eur Rev Med Pharmacol Sci. 2019; 23(2):708-715. DOI: 10.26355/eurrev_201901_16884. View

Chen J, Hu L, Wang J, Zhang F, Chen J, Xu G . Low Expression LncRNA TUBA4B is a Poor Predictor of Prognosis and Regulates Cell Proliferation in Non-Small Cell Lung Cancer. Pathol Oncol Res. 2016; 23(2):265-270. DOI: 10.1007/s12253-016-0089-y. View

Li C, Zheng H, Hou W, Bao H, Xiong J, Che W . Long non-coding RNA linc00645 promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma. Cell Death Dis. 2019; 10(10):717. PMC: 6763487. DOI: 10.1038/s41419-019-1948-8. View

Wang Z, Xiong J, Zhang S, Wang J, Gong Z, Dai M . Up-Regulation of microRNA-183 Promotes Cell Proliferation and Invasion in Glioma By Directly Targeting NEFL. Cell Mol Neurobiol. 2016; 36(8):1303-1310. PMC: 11482510. DOI: 10.1007/s10571-016-0328-5. View

Wahlestedt C . Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov. 2013; 12(6):433-46. DOI: 10.1038/nrd4018. View

10.

Fan H, Yuan R, Cheng S, Xiong K, Zhu X, Zhang Y . Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1. Biomed Pharmacother. 2018; 97:1554-1563. DOI: 10.1016/j.biopha.2017.11.050. View

11.

Hu X, Shen G, Lu X, Ding G, Shen L . Identification of key proteins and lncRNAs in hypertrophic cardiomyopathy by integrated network analysis. Arch Med Sci. 2019; 15(2):484-497. PMC: 6425197. DOI: 10.5114/aoms.2018.75593. View

12.

Guo J, Li Y, Duan H, Yuan L . LncRNA TUBA4B functions as a competitive endogenous RNA to inhibit gastric cancer progression by elevating PTEN via sponging miR-214 and miR-216a/b. Cancer Cell Int. 2019; 19:156. PMC: 6556040. DOI: 10.1186/s12935-019-0879-x. View

13.

Yang Z, Zhong L, Zhong S, Xian R, Yuan B . Adenovirus encoding Smad4 suppresses glioma cell proliferation and increases apoptosis through cell cycle arrest at G1 phase. Int Immunopharmacol. 2015; 25(1):169-73. DOI: 10.1016/j.intimp.2015.01.022. View

14.

Zhu F, Zheng F, Wang H, Zheng J, Zhang Q . Downregulation of lncRNA TUBA4B is Associated with Poor Prognosis for Epithelial Ovarian Cancer. Pathol Oncol Res. 2017; 24(2):419-425. DOI: 10.1007/s12253-017-0258-7. View

15.

Li J, He M, Xu W, Huang S . LINC01354 interacting with hnRNP-D contributes to the proliferation and metastasis in colorectal cancer through activating Wnt/β-catenin signaling pathway. J Exp Clin Cancer Res. 2019; 38(1):161. PMC: 6463672. DOI: 10.1186/s13046-019-1150-y. View

16.

Oberheim Bush N, Chang S, Berger M . Current and future strategies for treatment of glioma. Neurosurg Rev. 2016; 40(1):1-14. DOI: 10.1007/s10143-016-0709-8. View

17.

Shi D, Wu F, Mu S, Hu B, Zhong B, Gao F . LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway. J Exp Clin Cancer Res. 2019; 38(1):375. PMC: 6708246. DOI: 10.1186/s13046-019-1363-0. View

18.

Gu L, Jin S, Xu R, Zhang J, Geng Y, Shao X . Long non-coding RNA PCAT-1 promotes tumor progression by inhibiting miR-129-5p in human ovarian cancer. Arch Med Sci. 2019; 15(2):513-521. PMC: 6425202. DOI: 10.5114/aoms.2018.75534. View

19.

Tanaka H, Sasayama T, Tanaka K, Nakamizo S, Nishihara M, Mizukawa K . MicroRNA-183 upregulates HIF-1α by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells. J Neurooncol. 2012; 111(3):273-83. DOI: 10.1007/s11060-012-1027-9. View

20.

Shao S, Tian J, Zhang H, Wang S . LncRNA myocardial infarction-associated transcript promotes cell proliferation and inhibits cell apoptosis by targeting miR-330-5p in epithelial ovarian cancer cells. Arch Med Sci. 2018; 14(6):1263-1270. PMC: 6209713. DOI: 10.5114/aoms.2018.75535. View